Epigenomics AG (FRA:ECX)
Germany · Delayed Price · Currency is EUR 0.9000
0.00 (0.00%)
At close: Sep 18, 2026
Epigenomics AG Market Cap
Epigenomics AG has a market cap or net worth of €789.28 thousand as of September 18, 2026. Its market cap has increased by 5.89% in one year.
Market Cap
789.28K
Enterprise Value
11.89M
Revenue
30.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.90
ChartMarket Cap Chart
Since September 22, 2014, Epigenomics AG's market cap has decreased from 52.02M to 789.28K, a decrease of -98.48%. That is a compound annual growth rate of -29.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 789.28K | - |
| Dec 30, 2025 | 789.25K | -19.48% |
| Dec 30, 2024 | 980.17K | -38.24% |
| Dec 29, 2023 | 1.59M | -76.50% |
| Dec 30, 2022 | 6.75M | -17.48% |
| Dec 30, 2021 | 8.18M | -57.46% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 56.46B |
| Bayer Aktiengesellschaft | 48.18B |
| Siemens Healthineers AG | 42.04B |
| Fresenius SE & Co. KGaA | 25.97B |
| NanoRepro AG | 21.44M |
| Maternus-Kliniken Aktiengesellschaft | 18.24M |
| Biofrontera AG | 15.07M |
| Geratherm Medical AG | 13.26M |